China Youth News: The medicine price is empty and high Unreasonable to rise in price and will be driven out of the medical insurance catalogue

China Youth News: The medicine price is empty and high Unreasonable to rise in price and will be driven out of the medical insurance catalogue
The rustle of leaves in the wind of the medicine price is attracting the concern of the whole society. On June 17, this newspaper reports some medical insurance catalogue medicines rise in price quietly, on the same day, the national development and reform committee sends out the file promptly, require all parts to be thorough and check this. At the end of June, national development and reform committee Pricing Department is interviewed by reporter on this. This company relevant person in charge say, readjust the price not unreasonable by oneself enterprise, try to persuade and warn it and resume original price. If enterprises do not hear and admonish, the local price department may propose bidding and purchasing the department and cancelling the qualification of its bid. If enterprises do not still mind, can make the situation the department to the national medical insurance catalogue to reflect in losing and winning a bid of the qualification, propose studying its medicines qualification of medical insurance again. The medicine price is empty and high, where is the question lain in Different persons have different understanding on medicine price. In the view of relevant personage of national development and reform committee Pricing Department, it is the price that the question that the medicine price reflects is not simple, but various contradictions in the system is operated. If the system has been obeyed, the market has fully competed, does not need government's administered price at all. The existing one raises and cures the distortion of the system, medical domain income distribution system with medicine, have caused the distortion of the medicine price. "The hospital also needs medicines to raise, this is allowed by a policy too, the finance does not have so many to put into to the hospital, the hospital needs to sell medicines and making money and keeping on the go. " Personage this say on the other hand, doctor income high name have, greatly work that do. There are varied expenses and was supported by enterprise in the construction of hospital - -The money which the doctor trained, exchanged, it is that the hospital appears more or less not to have. If can pay the channel for these expenses which raised medicine to solve, the income distribution relation has been made in order, empty high problem has been solved at the price. In his view, in view of total amount of the expenses, the medical expenses of per person of our country are not higher than that of the other countries, even lower one. He tell reporter whether compare with, study through world, of our country chemical the intersection of medicines and the intersection of price and than developed countries such as the United States and Japan,etc. level, new developing economic developed countries of the Asian-Pacific area such as Brazil, South Korea,etc. are all low. "The problem is, it is seriously unreasonable that the expenses form structure. Unless it is mend to compensate this medical care, offer what finance pay the bill,should bear medicine price but not bear, so the medicine price is empty and high. " This personage says, the ordinary people of our country think medicine has high price, mainly because the guarantee level of our country still remains to improve. The health care system reform already started will solve the present existing problem progressively. According to this kind of understanding, if the system of raising medicine with medicine is broken, the compensation mechanism of hospital, doctor is implemented, the empty and high problem of the medicine price is no longer a question. But at this stage at present, how to adjust the medicine price? The above-mentioned country Pricing Department of development and reform committee personage says, the present method is making a reduction progressively on the basis of current market price, in order to meet raising and curing the system with medicine, change the system, improve compensation mechanism while pushing the space of price. Adjusted by a few years, crowd the space of empty high price that the market has already transformed into out progressively. "This kind of method accords with the overall thinking of the reform of our country. The ability to work that push the frequentness of the price and the efforts depends on us, depend on the process of system and mechanism's reform. If the system is not changed, can not promote. Will change whether to or even promoted or not. " This personage says. Enter the phenomenon that catalogue medicines of medical insurance rise in price newly as to some, the relevant personage of national development and reform committee Pricing Department tells reporters, enterprises raise the price, some really belong to the cost and rise to need, have some to bid and purchase for dealing with, and influence the next government issused price. "We not merely see the price that enterprises raised, enterprises are actually busy oneself to no purpose alive. " This personage says. According to his introduction, the national development and reform committee understands medicine price mainly passes 4 channels, including: Price, key hospital of provinces and cities that price department of all parts appear in the newspaper purchase bid, all parts, call for bid price, and the trade price of the key large-scale commercial company. He says, it is useless to change prices only in a channel and will let the development and reform committee think inside problematic instead. "Make forced quotation from entering the medical insurance catalogue to the government, does not repel and raise the price rationally in law, it is unreasonable but if rise in price, the order that will disrupt the market. " "A domestic a large number of low-level pharmaceutical factory competition, producer must hospitals public relation. In order to let the hospital choose oneself in calling for bid, some enterprises will force up commodity prices before calling for bid. The higher the price is, the larger the addition profit after selling of the hospital is, the hospital likes such medicines. " A reputable personage in the industry says, the surging one is the hospital, but the hospital is hurt and wronged, all the doctor's bonus must come from the expenses for medicine. This insider says, everybody has opinions timid and high on the medicine price, but if in view of procedure, it seems that each link is out of question. The hospital will say, this is that the medicines which Ministry of Health organizes call for bid, the Ministry of Health says that the price is at the forced quotation of price department to call for bid, the price department says that has only stipulated the ceiling price, and calculate according to associated documents, also there is no question. "Where is the question lain in? " This personage says, it seems to be should be that the data go wrong, then the spearhead has pointed to the platform of calling for bid. Because some call for bid the platform is the operation of commercial company, it is deceived that really sometimes both ends exist. But no longer use the bid platform of the commercial company, are the ones that can guarantee the data true? If can't solve the problem of raising medicine with medicine, the medicine price will rise through the way of others. Whether the medicine price is really high according to our country's present medicine price management system, the price of medicines has three kinds of forms. The data that the national development and reform committee offers reveal, medicines bought, released to the particular crowd free by the finance, implement the government issused price, nearly there are 100 kinds at present, accounts for about 0.8% that have already sanctioned the quantity of listing medicines; Medical insurance medicines implement the government guided price, the concrete form is the forced quotation of the supreme retail, about 2600 kinds, accounts for about 22%. Other medicines implement the market regulation, accounts for about 77% by enterprise's independent pricing. Before 2000, the country is dispatched from the factory, sells the price of all links in batches, retails to manage medicines completely. After 2000, decontrolled medicines and is dispatched from the factory, sells the price control of links in batches, just managed retail link, direct embodiment is the restriction on the thing that entering, national medical insurance catalogue medicines carry on the supreme retail price. Since 2000, dilatation 3 times of national medical insurance catalogue, include in medicines of government issused price and government guided price range, have risen to present 2700 kinds from 200 multi-type. The statement of using the national development and reform committee is, " follow the medical insurance catalogue and pigeonhole prices among 10 years. " The relevant personage of national development and reform committee Pricing Department tells reporters, entered the medicines price of the catalogue to already almost kept in 2000, the medicines price that entered the medical insurance catalogue in 2004 has extrusion to a certain degree too, will enter the medical insurance eye in 2009 The medicines price recorded has not begun to crowd yet. He say, static behavior watch the intersection of medical insurance and the intersection of catalogue and the intersection of medicine and price, will find some? Sweet-smelling Luangge of Zou Lian zinc account for the intersection of Xi and tribute wash the intersection of Xi and the intersection of �� and the intersection of tool instrument and the intersection of brain and ��, girl of Kuo, wave hard silk, account for cold the intersection of �� and tool instrument, herd ��, hook of ��, abate foot-path disease arc even slowly? "The price of some medicines, the already so low that we get stage that should be improved. " He says, over the past 10 years, economy is developed fast, the improvement by a wide margin of the salary income, the factors of production such as being artificial of enterprises are rising greatly too. If the price does not carry on dynamic adjustment, some medicines enterprises have no idea production. In the medicines of government guided price, some must have the intersection of price and space, some very much little space, some have even already lost money. For the previous period, a director of dept. of dermatology of BJ Univ Hospital is written to by the national development and reform committee, appeal for improving the sulphone price of ammonia benzene that the clinic needs, this kind of medicine does not have enterprise's production, the reason is too cheap, just 18 yuan for 1000 sheets. And caused one scene of incidents of asparagus that the society paid close attention to extensively recently, it was the empty and high typical example of pricing of medicines. Asparagus block at only 15.5 yuan of producer price, sell to consumers at 213 yuan in a hospital of Hunan. And it is given in Hunan Province Price Bureau that this price is exactly the supreme retail price of this medicine. Office this say because of understand enough abundant information, lead to the fact, give bid of enterprise offer, instruct price to be on the high side recently. Also some medicines manufacturing enterprises reflect to the reporter, the price forming mechanism of medicines of our country is not complete yet, sometimes enterprises feel wronged too. Produce fragrant alkene of olives and take orally in lactic Dalian China and set up the person in charge of Pharmaceutcal Co., Ltd. of gold harbour to tell reporters, fragrant alkene of olive that this company produces is that our country has medicine of original patent for invention of the independent intellectual property right. But since the products went on the market, suffered the loss over the years. "The previous input of research and development of oral milk of fragrant alkene of olive is more than 50 million, the raw materials are rising in price constantly, GMP authorize transforming, renewal of the equipment, rising in price, cost of labor of water, electricity and gas of factory building and rise in price and suffer the loss over the years after the factor is causing this product to be listed. " This person in charge says, the company applied to readjust the price to Liaoning Province Price Bureau many times from 2005 to 2009, Liaoning Province Price Bureau is surveyed and studied and verified, agrees to adjust the price. In the view of this person in charge, the reason which presents this kind of phenomenon lies in, it is not enough to support original innovative medicine on the mechanism of the fixed price in our government, the price basically keeps dropping to invent new medicine originally after entering the medical insurance catalogue, enterprises have no profit to put into original medicine and research and develop, enter the vicious circle. Person in charge this tell reporter, in put into very big at new medicine researched and developed overseas-funded enterprise, the input of research and development of a new medicine can be up to 300 million - 500 million dollars. Because of the price mechanism marketization of overseas-funded enterprise, the profit is very much generous, there is money to drop new medicine into and research and develop and enter benign cycle. Now, foreign capitals the intersection of medicine and the intersection of enterprise and products market share loud in the intersection of our country and medicines, the domestic-investment space of enterprise's market is smaller and smaller. "If enterprises invest a large number of manpower and materials financial resources to research and develop new medicine, and original innovative medicine suffers the loss after going on the market, enterprises do not do original innovative medicine to research and develop later, Chinese health is grasped in foreign enterprise. " This person in charge says. Also enterprises say, have been carrying out the national pricing policy strictly all the time. It says more than a Shenzhen Company of the star's, this product entered the national medical insurance catalogue in 2004 to produce A gently. 2006, according to national the intersection of development and reform committee and associated documents, this company A gentle to become, price at medicines alone than the intersection of star and products, national forced quotation costs 121 yuan for each one. This product has been carrying out the price that the national supreme retail price is being limited in the sale of province and city such as Shandong, Shanghai,etc. all the time. The examination and approval of different responsible institutions is not totally connected, who has the final say The medicine price is only a figure, that was hidden behind this figure is the complicated logic. In the formulation of the medicine price, except that medicines produce production costs and enterprise's profits such as raw materials, artificial expenses, business administration cost, circulation costs,etc., another important factor is determining the level of the medicine price. This factor, asserting to medicines innovative intensity, comprehensive cost performance. On this aspect, medicines have medicine of patent, grind medicines, different kinds of new medicines originally, model medicines, price alone differentiation of different nature such as medicine, these define difference of medicines, has determined different price echelon after entering the market of these medicines directly. According to our country's present medicines pricing mechanism, it is the most top-grade that medicine of patent belongs to medicines to innovate, can enjoy the supreme profit space, if a piece of medicines can obtain the patent, that can be on the fixed price in the lead. Good and achieving and throwing and managing Zhang XiaoLong, executive director of company, and sending mails to refer to to the reporter, after Jinzhou the intersection of and the intersection of swan and the intersection of medicine company and the intersection of Co., Ltd. and injection of production congeal the enzyme Nation pavilion and is listed with white the intersection of eyebrow and the intersection of snake venom and blood, enterprises carried on input of research and development and technological innovation, obtained the patent for invention of products that the Chinese intellectual property office issues in 2008. This patent brings the advantage at prices. Grind medicine, belong to, price alone in price originally, can enjoy more the intersection of profit and space modelling medicining, there is relative protection properties in forced quotation of calling for bid, policy, making a reduction,etc. is assaulted. According to the current " method of government issused price of medicines ", original reseach medicines of protection period of patent already pass and invent the country and model medicines more than what GMP enterprises produced, the injection price differential rate can be up to 35% at most, other form price differential rates can be up to 30% at most. Model the bottom that medicines are not all in the price either. According to the introduction of relevant personage of national development and reform committee Pricing Department, if it is more effectual than other medicines to model medicine quality criteria some high, can price alone. The pricing concrete method that and it could be single to determine, prove and vote to fix through the expert. This means, should obtain higher price, more profit spaces, enterprises need to get the above-mentioned difference to assert for one's own medicines. In the industry reputable personage tell reporter whether domestic some enterprise put in at medicines innovate energy, but use one's head on things such as dosage form, specification, packing,etc., once these little changes are approved by relevant approval of department, there are spaces in rising in price. "There are medicines to clear up slice and accuse of clearing up slice slowly, pricing is different. Relevant department criticize, accuse of, clear up slice slowly later, enterprise so as, can come with two kind preceding difference in price. " This personage says. These different circle rules come from different administrative departments. Who decides a medicines are medicine of patent, grind medicines originally, or model medicines? Some medicines, it is four kinds of new medicines when national Bureau of Drugs Supervision register examination and approval at first, but this manufacturer received the patent of State Patent Office a few years later, having become medicine of patent, the price has spaces raised; Some medicines, already protection period has passed in the foreign patent that had, are entering the Chinese market When, the examination and approval of him of Ministry of Health is only three kinds of new medicines too, after pricing through GMP of a few years, but this medicines enter the single pricing catalogue of the national development and reform committee; There are some medicines, examine and approve according to a kind of new medicine when national Bureau of Drugs Supervision register to examine and approve, but on the pricing policy, the national development and reform committee, to grinding asserting that does not see whether Bureau of Drugs Supervision sanctions as a kind of new medicine of medicine originally The patents of registered examination and approval, State Patent Office of national Bureau of Drugs Supervision are examined and approved, and the asserting of medicines to grinding medicines originally, pricing alone of national development and reform committee, these assert that does not totally connect each other. And there are different judgement standard and policy guide between these relevant departments, enterprises have a chance to visit and go the space of policy. "There is a question in connecting in the policy at present. " This personage says, national Bureau of Drugs Supervision registers and examines and approves and examine and approve and has not connected with the patent office patent to medicines, standards examined each other are different, out of step too on time. It would be ordinary medicines when registering examination and approval if this causes some medicines, but get the patent for invention of the patent office in a few years. "In the single pricing policy, though there are objective indexes, there are expert's subjective factors too. This policy began to try in 2001, there were more contradictions. Suspended after 2005. " This personage says. This personage says, the national development and reform committee has already noticed the system connects the question on, soliciting and proposing in the suggestion " price management of medicines ", will consider Bureau of Drugs Supervision together about the patent standards of registered standard and State Patent Office of new medicine in the future, two none of can be dispensed with. Should really innovate, as well as pay attention to the intellectual property right. (Li SongTao)

|